Ceruloplasmin protects against rotenone-induced oxidative stress and neurotoxicity

Neurochemical Research

Volumn 36, Issue 11, 2011, Pages 2127-2135

  Hineno, Akiyo ^a   Kaneko, Kazuma ^a   Yoshida, Kunihiro ^a   Ikeda, Shu Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antioxidant; Ceruloplasmin; Iron; Oxidative stress; Rotenone

Indexed keywords

CERULOPLASMIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE;

ACERULOPLASMINEMIA; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IRON METABOLISM; IRON TRANSPORT; LATENT PERIOD; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ALDEHYDES; ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; CERULOPLASMIN; ELECTRON TRANSPORT COMPLEX I; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEUROTOXICITY SYNDROMES; OXIDATIVE STRESS; ROTENONE;

MUS;

EID: 80055015421     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0537-8     Document Type: Article

References (40)

1. V Vassiliev ZL Harris P Zatta 2005 Ceruloplasmin in neurodegenerative diseases Brain Res Rev 49 633 640 16269323 10.1016/j.brainresrev.2005.03.003 1:CAS:528:DC%2BD2MXhtFOhsbrE (Pubitemid 41546662)
2. J Healy K Tipton 2007 Ceruloplasmin and what it might do J Neural Transm 114 777 781 17406962 10.1007/s00702-007-0687-7 1:CAS:528:DC%2BD2sXls1SgsbY%3D (Pubitemid 46980484)
3. G Floris R Medda A Padiglia, et al. 2000 The physiopathological significance of ceruloplasmin. A possible therapeutic approach Biochem Pharmacol 60 1735 1741 11108788 10.1016/S0006-2952(00)00399-3 1:CAS:528: DC%2BD3cXosFCitrs%3D
4. BN Patel S David 1997 A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes J Biol Chem 272 20185 20190 9242695 10.1074/jbc.272.32.20185 1:CAS:528:DyaK2sXltlGktbc%3D (Pubitemid 27340128)
5. Y Ke ZM Quan 2007 Brain iron metabolism: neurobiology and neurochemistry Prog Neurobiol 83 149 173 17870230 10.1016/j.pneurobio.2007.07.009 1:CAS:528:DC%2BD2sXhtFSntrnJ (Pubitemid 47484044)
6. JA Gaasch PR Lockman WJ Geldenhuys, et al. 2007 Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells Neurochem Res 32 1196 1208 17404839 10.1007/s11064-007-9290-4 1:CAS:528: DC%2BD2sXlslCmu7g%3D (Pubitemid 46817469)
7. EE Benarroch 2009 Brain iron homeostasis and neurodegenerative disease Neurology 72 1436 1440 19380704 10.1212/WNL.0b013e3181a26b30
8. H Morita S Ikeda K Yamamoto, et al. 1995 Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family Ann Neurol 37 646 656 7755360 10.1002/ana.410370515 1:STN:280: DyaK2M3nsFSisw%3D%3D
9. K Kaneko K Yoshida K Arima, et al. 2002 Astrocytic deformity and globular structures are characteristic of the brains of patients with aceruloplasminemia J Neuropathol Exp Neurol 61 1069 1077 12484569 (Pubitemid 35435025)
10. T Oide K Yoshida K Kaneko, et al. 2006 Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia Neuropathol Appl Neurobiol 32 170 176 16599945 10.1111/j.1365-2990.2006.00710.x 1:CAS:528: DC%2BD28XkslantLY%3D
11. S Kohno H Miyajima Y Takahashi, et al. 2000 Defective electron transfer in complexes I and IV in patients with aceruloplasminemia J Neurol Sci 182 57 60 11102640 10.1016/S0022-510X(00)00452-4 1:STN:280:DC%2BD3M7js1Whug%3D%3D
12. K Yoshida K Kaneko H Miyajima, et al. 2000 Increased lipid peroxidation in the brains of aceruloplasminemia patients J Neurol Sci 175 91 95 10831768 10.1016/S0022-510X(00)00295-1 1:CAS:528:DC%2BD3cXjsVGht7Y%3D (Pubitemid 30265474)
13. K Kaneko A Nakamura K Yoshida, et al. 2002 Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain Free Radic Res 36 303 306 12071349 10.1080/10715760290019327 1:CAS:528: DC%2BD38XotFGmsbs%3D (Pubitemid 35154074)
14. K Yamamoto K Yoshida Y Miyagoe, et al. 2002 Quantitative evaluation of expression of iron-metabolism genes in ceruloplasmin-deficient mice Biochem Biophys Acta 1588 195 202 12393173 1:CAS:528:DC%2BD38XotVKqurY%3D (Pubitemid 35223462)
15. L Zecca MBH Youdim P Riederer, et al. 2004 Iron, brain ageing and neurodegenerative disorders Nat Rev Neurosci 5 863 873 15496864 10.1038/nrn1537 1:CAS:528:DC%2BD2cXos1Ojtrc%3D (Pubitemid 39482155)
16. M Whitnall DR Richardson 2006 Iron: a new target for pharmacological intervention in neurodegenerative diseases Semin Pediatr Neurol 13 186 197 17101458 10.1016/j.spen.2006.08.008 (Pubitemid 44709656)
17. F Molina-Holgado RC Hider A Gaeta, et al. 2007 Metal ions and neurodegeneration Biometals 20 639 654 17294125 10.1007/s10534-006-9033-z 1:CAS:528:DC%2BD2sXltlaqsrs%3D (Pubitemid 46776561)
18. S Raha BH Robinson 2000 Mitochondria, oxygen free radicals, disease and ageing Trends Biochem Sci 25 502 508 11050436 10.1016/S0968-0004(00)01674-1 1:CAS:528:DC%2BD3cXos1aqsbg%3D
19. R Betarbet TB Sherer G MacKenzie, et al. 2000 Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat Neurosci 3 1301 1306 11100151 10.1038/81834 1:CAS:528:DC%2BD3cXosVGgsbg%3D
20. VN Uversky 2004 Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration Cell Tissue Res 318 225 241 15258850 10.1007/s00441-004-0937-z 1:CAS:528:DC%2BD2cXos1aqsLk%3D (Pubitemid 39362642)
21. N Lapointe M St-Hilaire MG Martinoli, et al. 2004 Rotenone induces non-specific central nervous system and systemic toxicity FASEB J 18 717 719 14766796 1:CAS:528:DC%2BD2cXjtVyrs7o%3D
22. R Betarbet RM Canet-Aviles TB Sherer, et al. 2006 Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system Neurobiol Dis 22 404 420 16439141 10.1016/j.nbd.2005.12.003 1:CAS:528:DC%2BD28XktVyjs7g%3D (Pubitemid 44294281)
23. F Richter M Hamann A Richter 2007 Chronic rotenone treatment induces behavioral effects but no pathological signs of parkinsonism in mice J Neurosci Res 85 681 691 17171705 10.1002/jnr.21159 1:CAS:528:DC%2BD2sXjtFOksL8%3D
24. AI Rojo C Cavada MR de Saqarra, et al. 2007 Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats Exp Neurol 208 120 126 17880941 10.1016/j.expneurol.2007.07.022 1:CAS:528:DC%2BD2sXht1anurvL (Pubitemid 47600154)
25. H Takeuchi T Yanagida M Inden, et al. 2009 Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models J Neurosci Res 87 576 585 18803299 10.1002/jnr.21869 1:CAS:528: DC%2BD1MXhvFCrsbY%3D
26. M Inden Y Kitamura M Abe, et al. 2011 Parkinsonian rotenone mouse model: reevaluation of long-term administration of rotenone in C57BL/6 mice Biol Pharm Bull 34 92 96 21212524 10.1248/bpb.34.92
27. KS Saravanan KM Sindhu KP Mohanakumar 2007 Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model J Pineal Res 42 247 253 17349022 10.1111/j.1600-079X.2006.00412.x 1:CAS:528: DC%2BD2sXltFCntbc%3D (Pubitemid 46365061)
28. R Hosamani Muralidhara 2009 Neuroprotective efficacy of Bacopa monnieri against rotenone induced oxidative stress and neurotoxicity in Drosophila melanogaster Neurotoxicology 30 977 985 19744517 10.1016/j.neuro.2009.08.012 1:CAS:528:DC%2BD1MXhsFaiur%2FN
29. I Abdulwahid Arif H Ahmad Khan 2010 Environmental toxins and Parkinson's disease: putative roles of impaired electron transport chain and oxidative stress Toxicol Ind Health 26 121 128 20207656 10.1177/0748233710362382
30. G Tórsdóttir S Sveinbjörnsdóttir J Kristinsson, et al. 2006 Ceruloplasmin and superoxide dismutase (SOD1) in Parkinson's disease: a follow-up study Neurol Sci 241 53 58 10.1016/j.jns.2005.10.015 (Pubitemid 43112516)
31. KJ Bharucha JK Friedman AS Vincent, et al. 2008 Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson's disease J Neurol 255 1957 1962 19159062 10.1007/s00415-009-0063-7 1:CAS:528:DC%2BD1MXislSqsro%3D
32. K Kaneko A Hineno K Yoshida, et al. 2008 Increased vulnerability to rotenone-induced neurotoxicity in ceruloplasmin-deficient mice Neurosci Lett 446 56 58 18804145 10.1016/j.neulet.2008.08.089 1:CAS:528:DC%2BD1cXht1KntrfK
33. T Costa LC Constantino BP Mendonça, et al. 2010 N-methyl-D-aspartate preconditioning improves short-term motor deficits outcome after mild traumatic brain injury in mice J Neurosci Res 88 1329 1337 19998488 1:CAS:528:DC%2BC3cXisFakurw%3D
34. K Kumakura H Nomura T Toyoda, et al. 2010 Hyperactivity in novel environment with increased dopamine and impaired novelty preference in apoptosis signal-regulating kinase 1 (ASK1)-deficient mice Neurosci Res 66 313 320 20006657 10.1016/j.neures.2009.12.003 1:CAS:528:DC%2BC3cXitVaqu7c%3D
35. IT Kudva RW Griffin JM Garren, et al. 2005 Identification of protein subset of anthrax spore immunome in humans immunized with the anthrax vaccine adsorbed preparation Infect Immun 73 5685 5696 16113286 10.1128/IAI.73.9.5685- 5696.2005 1:CAS:528:DC%2BD2MXps1Gkt7o%3D (Pubitemid 41193004)
36. AY Andreyev YK Kushnareva AA Starkov 2005 Mitochondrial metabolism of reactive oxygen species Biochemistry (Moscow) 70 200 214 10.1007/s10541-005- 0102-7 1:CAS:528:DC%2BD2MXislamsbc%3D (Pubitemid 40512329)
37. AA Starkov 2008 The role of mitochondria in reactive oxygen species metabolism and signaling Ann NY Acad Sci 1147 37 52 19076429 10.1196/annals.1427.015 1:CAS:528:DC%2BD1MXhsVaqtb4%3D
38. +, or paraquat Proc Natl Acad Sci USA 105 15136 15141 18812510 10.1073/pnas.0807581105 1:CAS:528:DC%2BD1cXht1aqtbnJ
39. A Padiglia R Medda A Lorrai, et al. 1997 Modulation of 6-hydroxydopamine oxidation by various proteins Biochem Pharmacol 53 1065 1068 9175710 10.1016/S0006-2952(96)00716-2 1:CAS:528:DyaK2sXjtFersr8%3D (Pubitemid 27224251)
40. RL Atanasiu D Stea MA Mateescu, et al. 1998 Direct evidence of caeruloplasmin antioxidant properties Mol Cell Biochem 189 127 135 9879663 10.1023/A:1006945713860 1:CAS:528:DyaK1MXktV2jug%3D%3D (Pubitemid 28556557)